白石 真大 (シライシ マサヒロ)

北海道大学病院 中央診療施設等 集中治療部助教

研究者基本情報

■ 学位
  • 医学博士, 北海道大学, 2024年03月
■ URL
researchmap URLホームページURL■ ID 各種
ORCID IDJ-Global ID■ 研究キーワード・分野
研究キーワード
  • 先天性心疾患
  • 心血管機能
  • 心不全
研究分野
  • ライフサイエンス, 循環器内科学
  • ライフサイエンス, 胎児医学、小児成育学

経歴

■ 経歴
経歴
  • 2020年04月 - 現在
    北海道大学大学院・医学研究院 小児科学教室
  • 2025年10月 - 2026年03月
    江別市立病院 小児科
  • 2024年10月 - 2024年11月
    Freeman Hospital, Newcastle upon Tyne, UK, Pediatric Cardiology, AEPC-JSPCCS short term exchange
  • 2019年07月 - 2020年03月
    北海道立子ども総合医療・療育センター 循環器内科
  • 2015年04月 - 2019年06月
    千葉県こども病院 循環器内科
  • 2014年04月 - 2015年03月
    手稲渓仁会病院 小児科 (後期研修医)
  • 2012年04月 - 2014年03月
    北海道立子ども総合医療・療育センター (後期研修医)
  • 2010年04月 - 2012年03月
    NTT東日本札幌病院 (初期研修医)
学歴
  • 2020年04月 - 2024年03月, 北海道大学大学院, 医学研究院, 小児科学分野, (医学博士)
  • 2004年04月 - 2010年03月, 北海道大学, 医学部, 医学科

研究活動情報

■ 受賞
  • 2024年09月, 第10回北海道大学部局横断シンポジウム研究助成採択 奨励賞
    ミトコンドリア活性化ヒト由来細胞を用いた細胞移植療法の確立
  • 2023年04月, Association for European Pediatric and Congenital Cardiology, Young Investigator Award 2023
    “Human cardiosphere-derived cells with activated mitochondria forbetter myocardial regenerative therapy”
  • 2022年10月, 第43回 生体膜と薬物の相互作用シンポジウム 優秀発表賞
    「ミトコンドリア活性化ヒト由来心筋幹細胞を用いた心筋再生治療の検討」
  • 2022年03月, 北海道大学, DX 博士人材フェローシップ
  • 2021年03月, 北海道大学大学院医学研究院, 第40回 高桑榮松奨学基金奨励賞
  • 2017年07月, 日本小児循環器学会, Case Report Award
    Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant
■ 論文
  • Microcirculatory Alterations and Endothelial Glycocalyx in Fontan Circulation: Association With Central Venous Pressure.
    Masahiro Shiraishi; Gaku Izumi; Hitoshi Saito
    Microcirculation (New York, N.Y. : 1994), 33, 7, 2026年10月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), OBJECTIVE: Fontan circulation is characterized by chronically elevated central venous pressure (CVP) and reduced cardiac output, which may adversely affect the systemic microcirculation. We investigated whether Fontan circulation is associated with alterations of the endothelial glycocalyx. METHODS: Forty-four patients with congenital heart disease undergoing postoperative endothelial glycocalyx evaluation were included. The perfused boundary region (PBR), an inverse indicator of glycocalyx dimensions, was measured noninvasively using GlycoCheck. PBR was compared between patients with Fontan and biventricular circulation, and its relationship with CVP was evaluated. RESULTS: Fourteen patients had Fontan circulation, including three with bidirectional Glenn circulation, and 30 had biventricular circulation. PBR was significantly higher in patients with Fontan circulation than in those with biventricular circulation (2.07 ± 0.15 vs. 1.72 ± 0.17 μm, p < 0.0001). CVP was also significantly higher in the Fontan group (13.0 ± 2.2 vs. 7.1 ± 2.8 mmHg, p < 0.0001). PBR was positively correlated with CVP (r = 0.58, p < 0.0001). CONCLUSIONS: Fontan circulation is associated with an increased PBR, suggesting alterations of the endothelial glycocalyx. The association between PBR and CVP suggests that chronic venous hypertension may be associated with systemic microcirculatory alterations in Fontan circulation.
  • Trans MIT: microfluidically fabricated lipid nano capsules for robust intracellular delivery of mitochondria-derived components and metabolic enhancement
    Yuma Yamada; Momo Ito; Mitsue Hibino; Daisuke Sasaki; Masahiro Shiraishi; Jiro Abe; Mai Kanai; Masatoshi Maeki; Manabu Tokeshi; Yoshihiro Ohta; Hideyoshi Harashima
    MATERIALS TODAY ADVANCES, 31, 2026年08月, [査読有り]
    英語, 研究論文(学術雑誌)
  • CPP-PEG-Guided Surface Engineering of Mitochondria Enables Efficient Cellular Uptake and Respiratory Modulation
    Masahiro Shiraishi; Yukari Muramatsu; Akihiro Nakaya; Yuji Maruo; Rick C. Tsai; Masashi Suganuma; Hisashi Ohta; Atsuhito Takeda; Hideyoshi Harashima; Yuma Yamada
    ADVANCED MATERIALS INTERFACES, 2026年07月01日, [査読有り]
    英語, 研究論文(学術雑誌)
  • Alveolar Dead Space Fraction Predicts Prolonged Central Venous Pressure Elevation Following Perioperative Extubation in Patients After Fontan Surgery.
    Gaku Izumi; Masahiro Shiraishi; Itsumi Sato; Yu Matsumura; Yoji Tamaki; Takayuki Toki; Yusuke Itosu; Hiroki Katoh; Hitoshi Saito; Yuji Morimoto
    Journal of cardiothoracic and vascular anesthesia, 2026年05月16日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), OBJECTIVES: Early extubation after Fontan surgery is generally preferred because positive pressure ventilation increases central venous pressure (CVP). However, the optimal conditions for extubation that maintain stable Fontan hemodynamics remain unclear. The alveolar dead space fraction (AVDSF) has been reported to predict the need for prolonged ventilatory support. The authors hypothesized that AVDSF would predict prolonged CVP elevation after extubation following Fontan surgery. DESIGN: Retrospective observational study. SETTING: Single tertiary-care center. PARTICIPANTS: Patients younger than 10 years who underwent Fontan surgery at Hokkaido University Hospital between 2013 and 2023. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Preoperative hemodynamic variables and pre-extubation respiratory indices were assessed, including arterial carbon dioxide pressure, AVDSF, tidal volume-related parameters, rapid shallow breathing index, PaO₂/FiO₂ ratio, and alveolar-arterial oxygen difference. Unfavorable responses were defined as prolonged elevation of CVP or initiation and/or dose escalation of inhaled nitric oxide after extubation. Among 94 patients, 17 (18%) showed unfavorable responses. Firth's multivariable logistic regression identified AVDSF and preoperative pulmonary vascular resistance as independently associated with unfavorable responses. Receiver operating characteristic curve analysis showed cutoff values of AVDSF >0.12 (area under the curve 0.845, sensitivity 76.5%, specificity 92.2%) and pulmonary vascular resistance >1.55 Wood units (area under the curve 0.694, sensitivity 70.6%, specificity 68.7%). CONCLUSIONS: AVDSF was associated with prolonged elevation of CVP after extubation following Fontan surgery. An AVDSF value of around 0.12 may serve as an exploratory reference point for identifying patients at risk.
  • Mitochondrial Activation and Therapeutics: Innovations in Cell- and Organelle-Specific Medicine.
    Itsumi Sato; Masahiro Shiraishi; Kaede Norota; Kaoru Shiraki; Yuma Yamada
    Biological & pharmaceutical bulletin, 48, 11, 1652, 1666, 2025年, [査読有り], [国内誌]
    英語, 研究論文(学術雑誌), Mitochondria are essential for cellular functions, including ATP production, calcium homeostasis, oxidative stress regulation, and apoptosis. Mitochondrial dysfunction is associated with a variety of diseases, including neurodegenerative disorders, skeletal muscle diseases, and mitochondrial diseases. This review explores the latest mitochondrial-targeted therapeutic approaches across the following key perspectives: (1) technological innovations in mitochondrial transplantation, focusing on tunnel nanotubes and extracellular vesicles; (2) the role of mitochondria in skeletal muscle diseases and therapeutic activation strategies; (3) advances in mitochondrial enhancement techniques within cell therapy, particularly in pediatric applications; and (4) the latest treatment modalities for mitochondrial diseases, such as gene and cell therapies. Taken together, these strategies demonstrate the transformative potential of mitochondrial targeting in cell- and organelle-specific medicine. Additionally, the MITO-Porter system is highlighted as an innovative drug delivery platform contributing to these advances.
  • Human cardiosphere-derived cells with activated mitochondria for better myocardial regenerative therapy.
    Masahiro Shiraishi; Daisuke Sasaki; Mitsue Hibino; Atsuhito Takeda; Hideyoshi Harashima; Yuma Yamada
    Journal of controlled release : official journal of the Controlled Release Society, 2024年01月29日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), Cell transplantation is a promising therapeutic strategy for myocardial regeneration therapy. To improve therapeutic effects, we developed a culture medium additive that enhances the mitochondrial function of cardiomyocytes for transplantation. A mitochondrial targeting drug delivery system (MITO-Porter system) was used to deliver mitochondrial activation molecules to mouse-derived cardiac progenitor cells. In this study, we investigated whether the mitochondrial function of human-derived myocardial precursor cells could be enhanced using MITO-Porter. Human cardiosphere-derived cells (CDCs) were isolated from myocardium which was excised during surgery for congenital heart disease. MITO-Porter was added to the cell culture medium to generate mitochondrial activated CDCs (human MITO cells). The human MITO cells were transplanted into myocardial ischemia-reperfusion rat model rat, and the effect was investigated. The transplanted human MITO cells improved the cardiac function and suppressed myocardial fibrosis compared to conventional cell transplantation methods. These effects were observed not only with myocardial administration but also by intravenous administration of human MITO cells. This study is the first study that assessed whether the mitochondrial delivery of functional compounds improved the outcome of human-derived myocardial cell transplantation therapy.
  • Activation of Mitochondria in Mesenchymal Stem Cells by Mitochondrial Delivery of Coenzyme Q10.
    Yuji Maruo; Masahiro Shiraishi; Mitsue Hibino; Jiro Abe; Atsuhito Takeda; Yuma Yamada
    Biological & pharmaceutical bulletin, 47, 8, 1415, 1421, 2024年, [査読有り], [国内誌]
    英語, 研究論文(学術雑誌), The efficacy of mesenchymal stem cell (MSC) transplantation has been reported for various diseases. We previously developed a drug delivery system targeting mitochondria (MITO-Porter) by using a microfluidic device to encapsulate Coenzyme Q10 (CoQ10) on a large scale. The current study aimed to confirm if treatment with CoQ10 encapsulated by MITO-Porter enhanced mitochondrial functions in MSCs, with the potential to improve MSC transplantation therapy. We used highly purified human bone marrow-derived MSCs, described as rapidly expanding clones (RECs), and attempted to control and increase the amount of CoQ10 encapsulated in the MITO-Porter using microfluidic device system. We treated these RECs with CoQ10 encapsulated MITO-Porter, and evaluated its cellular uptake, co-localization with mitochondria, changes in mitochondrial respiratory capacity, and cellular toxicity. There was no significant change in mitochondrial respiratory capacity following treatment with the previous CoQ10 encapsulated MITO-Porter; however, mitochondrial respiratory capacity in RECs was significantly increased by treatment with CoQ10-rich MITO-Porter. Utilization of a microfluidic device enabled the amount of CoQ10 encapsulated in MITO-Porter to be controlled, and treatment with CoQ10-rich MITO-Porter successfully activated mitochondrial functions in MSCs. The MITO-Porter system thus provides a promising tool to improve MSC cell transplantation therapy.
  • A case of infantile Barth syndrome with severe heart failure: Importance of splicing variants in the TAZ gene.
    Atsuhito Takeda; Masahiro Ueki; Jiro Abe; Kazuhiro Maeta; Tomoko Horiguchi; Hirokuni Yamazawa; Gaku Izumi; Ayako Chida-Nagai; Daisuke Sasaki; Takao Tsujioka; Itsumi Sato; Masahiro Shiraishi; Masafumi Matsuo
    Molecular genetics & genomic medicine, 11, 7, e2190, 2023年04月25日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), Barth syndrome (BTHS) is an X-linked disorder characterized by cardiomyopathy, skeletal myopathy, and 3-methylglutaconic aciduria. The causative pathogenic variants for BTHS are in TAZ, which encodes a putative acyltransferase named tafazzin and is involved in the remodeling of cardiolipin in the inner mitochondrial membranes. Pathogenic variants in TAZ result in mitochondrial structural and functional abnormalities. We report a case of infantile BTHS with severe heart failure, left ventricular noncompaction, and lactic acidosis, having a missense c.640C>T (p.His214Tyr) variant in TAZ, which is considered a pathogenic variant based on the previously reported amino acid substitution at the same site (c.641A>G, p.His214Arg). However, in this previously reported case, heart function was compensated and not entirely similar to the present case. Silico prediction analysis suggested that c.640C>T could alter the TAZ messenger RNA (mRNA) splicing process. TAZ mRNAs in isolated peripheral mononuclear cells from the patient and in vitro splicing analysis using minigenes of TAZ found an 8 bp deletion at the 3' end of exon 8, which resulted in the formation of a termination codon in the coding region of exon 9 (H214Nfs*3). These findings suggest that splicing abnormalities should always be considered in BTHS.
  • Aortic root dilatation and aortic stiffness.
    Tomoaki Murakami; Masahiro Shiraishi; Koichiro Niwa
    Journal of hypertension, 40, 7, 1431, 1431, 2022年07月01日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • The sex difference in the association of enhanced brachial-ankle pulse wave velocity and adverse cardiac remodeling: the possible background mechanism.
    Tomoaki Murakami; Masahiro Shiraishi
    Journal of hypertension, 40, 7, 1432, 1432, 2022年07月01日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • What is the connection between body height and flow-mediated vasodilation?
    Tomoaki Murakami; Masahiro Shiraishi
    Hypertension research : official journal of the Japanese Society of Hypertension, 45, 7, 1220, 1220, 2022年07月, [査読有り], [国際誌]
    英語
  • Pulse pressure amplification is one of the important factors evaluating peripheral blood pressure during exercise.
    Tomoaki Murakami; Masahiro Shiraishi
    Journal of hypertension, 40, 6, 1245, 1245, 2022年06月01日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • Aortic dilatation influences on cardiovascular events; why?
    Tomoaki Murakami; Masahiro Shiraishi
    Journal of hypertension, 39, 9, 1929, 1929, 2021年09月01日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab.
    Ayako Chida-Nagai; Hiroki Sato; Itsumi Sato; Masahiro Shiraishi; Daisuke Sasaki; Gaku Izumi; Hirokuni Yamazawa; Kazutoshi Cho; Atsushi Manabe; Atsuhito Takeda
    European journal of pediatrics, 181, 2, 539, 547, 2021年08月21日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), Respiratory syncytial virus (RSV) is a common pathogen that causes extremely severe respiratory symptoms in the first few weeks and months of life. In infants with cardiopulmonary diseases, RSV infections have a significant clinical impact. Palivizumab, a humanised monoclonal antibody for RSV, has been shown to significantly reduce the rate of hospitalisation of high-risk infants diagnosed with RSV. However, we have experienced a significant number of RSV infections in our institution that required hospitalisation or intensive care, despite the administration of palivizumab. This study aimed to analyse the risk factors associated with severe RSV despite the use of palivizumab. We retrospectively reviewed the medical records of 688 patients who visited or were admitted to our hospital and received palivizumab. Thirty-seven (5.4%) patients required hospitalisation for RSV, despite receiving palivizumab. In addition, 31 of these patients (83.8%) required hospitalisation out of season for palivizumab injection. Preterm birth (≤ 28-week gestation), bronchopulmonary dysplasia (BPD), and trisomy 21 were risk factors for RSV-related hospitalisation in infected patients, despite receiving palivizumab. Furthermore, subgroup analysis of 69 patients with RSV revealed that hemodynamically significant congenital heart disease (CHD) was also a risk factor for RSV-related hospitalisation.Conclusion: Preterm birth (≤ 28 weeks of gestation), BPD, trisomy 21, hemodynamically significant CHD, and CHD requiring surgery or cardiac catheterisation/intervention during infancy could be considered when determining whether year-round administration of palivizumab is appropriate. What is Known: • Respiratory syncytial virus causes severe respiratory symptoms in infants, particularly those with cardiopulmonary diseases. • The use of palivizumab has reduced the rate of hospitalisation of infants diagnosed with RSV. Despite this, the rate of hospitalisation is still high. What is New: • We identified that preterm birth (≤ 28-week gestation), bronchopulmonary dysplasia, trisomy 21, and hemodynamically significant congenital heart disease were risk factors for RSV-related hospitalisation, even after receiving palivizumab treatment. • High-risk infants should be closely monitored and the prolonged use of palivizumab should be considered.
  • Hypertrophic Cardiomyopathy as Congenital Heart Disease.
    Tomoaki Murakami; Masahiro Shiraishi
    Journal of the American College of Cardiology, 77, 10, 1377, 1378, 2021年03月16日, [査読有り], [国際誌]
    英語
  • The relationship between aortic diameter and pulse wave velocity.
    Tomoaki Murakami; Masahiro Shiraishi; Taro Murakami
    Journal of hypertension, 38, 8, 1627, 1627, 2020年08月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • Reply.
    Masahiro Shiraishi; Tomoaki Murakami; Kouji Higashi
    Journal of hypertension, 38, 7, 1389, 1390, 2020年07月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • The accuracy of central blood pressure obtained by oscillometric noninvasive method using Mobil-O-Graph in children and adolescents.
    Masahiro Shiraishi; Tomoaki Murakami; Kouji Higashi
    Journal of hypertension, 38, 5, 813, 820, 2020年05月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), OBJECTIVES: Central blood pressure (CBP) can now be reliably measured noninvasively with a number of devices in adult; however, noninvasive assessment of CBP has not been validated in children and adolescents. The purpose of this study was to clarify the accuracy of noninvasive oscillometric CBP measurements in children and adolescents. METHODS: This study included 60 patients with an average age of 7.9 ± 4.4 years (range 1-18 years) who underwent a cardiac catheterization. We compared CBP, estimated with a noninvasive oscillometric method using a Mobil-O-Graph, with simultaneous invasive recordings using a catheter in children and adolescents. RESULTS: Comparison of the SBP values measured by the two methods, showing a linear correlation (r = 0.85; P < 0.0001) with the mean difference aortic SBP minus estimated central SBP of 2.0 ± 5.6 mmHg (95% limits of agreement = -9.0-13.1). In DBP values, there was a correlation (r = 0.72; P < 0.0001) with the mean difference aortic DBP minus estimated central DBP of -0.1 ± 6.4 mmHg (95% limits of agreement = -12.6-12.4). Sex and cardiac function did not affect central SBP estimation; however, the correlation between aortic and estimated central SBP in adolescents was better than that in children (r = 0.93, P < 0.0001 vs. r = 0.77, P < 0.0001), though the difference was not statistically significant (P = 0.483). CONCLUSION: Estimated CBP using Mobil-O-Graph in children and adolescents shows a certain degree of accuracy, which will be helpful in future for evaluating CBP in children and adolescents.
  • Significance of NT-proBNP as prognostic marker in patients with hypertension.
    Tomoaki Murakami; Masahiro Shiraishi; Taro Murakami
    Journal of hypertension, 38, 5, 975, 975, 2020年05月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • Attenuation of Pulse Pressure Amplification in Patients with Complete Transposition of the Great Arteries After an Arterial Switch Operation in Children.
    Tomoaki Murakami; Masahiro Shiraishi; Taro Murakami; Atsuhito Takeda
    Pediatric cardiology, 39, 8, 1561, 1564, 2018年12月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), Although the arterial switch operation has become the standard procedure for infants with complete transposition of the great arteries, possible late adverse events after surgery have not been fully elucidated. One such problem may be the postoperative function of the aorta that is radically manipulated. The current study enrolled 12 patients aged 4-9 years who had undergone an arterial switch operation. The ascending and descending aortic pressure waveforms were recorded by a catheter-mounted pressure sensor. The pressure values were compared with those of 28 age-matched controls. The mean patient age was 6.5 ± 1.0 years, and the mean age at the time of surgery was 15.2 ± 8.7 days. The pulse pressure in the ascending aorta was greater in the patients than in the controls (37.7 ± 5.7 vs. 33.5 ± 5.3 mmHg, p = 0.042), while no difference was observed at the descending aorta between the two groups (39.5 ± 5.1 vs. 37.4 ± 5.4 mmHg, respectively, p = 0.27). The pulse pressure amplification, defined as the pulse pressure in the descending aorta minus that in the ascending aorta, was significantly lower in patients who had undergone the arterial switch operation than in control patients (1.8 ± 1.6 vs. 4.0 ± 2.3 mmHg, p = 0.0052). The augmented pulse pressure in the ascending aorta and attenuated pulse pressure amplification observed in children treated with arterial switch surgery for complete transposition of the great arteries may implicate the procedure as a cause of future cardiovascular disease.
  • Impact of Pulmonary Valve Regurgitation on Pressure Difference of Pulmonary Valve Stenosis in Patients with Tetralogy of Fallot After Repair.
    Shinichiro Sakaki; Tomoaki Murakami; Masahiro Shiraishi; Mamoru Yamamoto
    Pediatric cardiology, 39, 8, 1663, 1668, 2018年12月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), Pressure difference (PD) is an important parameter in evaluating the degree of stenotic lesion. However, PD is influenced by the blood flow volume passing through the stenosis. In patients with tetralogy of Fallot (TOF), pulmonary valve regurgitation (PR) and pulmonary valve stenosis (vPS) are common post-operative complications. The aim of this study was to evaluate the influence of PR on the PD. First, we examined the relationship between the peak-to-peak PD and the valve orifice area in 7 patients with vPS from their cardiac catheterization data. Second, an estimated PD, i.e., PD assuming no PR, was calculated in 8 patients with TOF with vPS and PR from their valve orifice area using the relational equation in patients with vPS. Moreover, an excess of PD, equating to the difference between the measured and estimated PD, was calculated. Finally, the relationship between the regurgitant fraction (RF) and the excess PD was analyzed. There was a strong relationship between the reciprocal of the valve orifice area and the PD in patients with vPS (r = 0.904, p = 0.0053). The excess PD showed a significant correlation with the RF in patients with TOF (r = 0.889, p = 0.0032). PR of over 25% in RF augmented the PD depending on the regurgitant volume. Severity of vPS could be overestimated in post-operative patients with TOF who had significant PR when their RF was above 25%.
  • Letter by Murakami et al Regarding Article, "Risk of Dementia in Adults With Congenital Heart Disease: Population-Based Cohort Study".
    Tomoaki Murakami; Masahiro Shiraishi; Taro Murakami
    Circulation, 138, 15, 1615, 1615, 2018年10月09日, [査読有り], [国際誌]
    英語
  • Letter by Murakami et al Regarding Article, "Systemic Right Ventricle in Adults with Congenital Heart Disease: Anatomic and Phenotypic Spectrum and Current Approach to Management".
    Tomoaki Murakami; Masahiro Shiraishi; Taro Murakami
    Circulation, 138, 3, 324, 325, 2018年07月17日, [査読有り], [国際誌]
    英語
  • Low Peak dP/dt in the Descending Aorta in Patients After Successful Aortic Arch Repair.
    Masahiro Shiraishi; Tomoaki Murakami; Atsuhito Takeda
    Pediatric cardiology, 39, 3, 533, 537, 2018年03月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), One of the most important problems in patients with aortic coarctation or interruption of the aortic arch after successful aortic arch repair is developing cardiovascular disease in the future. It has been reported that the repaired site is stiff and generates a new pressure wave reflection, which could lead to cardiovascular disease. The purpose of this study was to clarify the influence of the repaired portion's stiffness on the pressure waveform in patients. Fifteen patients (age: 7.4 ± 3.2 years) who had successful aortic arch repair were enrolled. Their peak dP/dt in the ascending aorta (AAo) and the descending aorta (DAo) were compared with those of age-matched controls with a normal aortic arch. The ascending and descending aortic systolic blood pressures in aortic arch repair patients were higher than those in age-matched controls (AAo: 103.1 ± 13.3 vs. 91.9 ± 9.2 mmHg, p = 0.012 and DAo: 108.7 ± 16.4 vs. 96.5 ± 9.9 mmHg, p = 0.020). Although no difference existed in the peak dP/dt in the AAo between the aortic arch repair patients and the controls (572.1 ± 100.1 vs. 543.3 ± 110.2 mmHg/s, p = 0.460), the peak dP/dt in the DAo in the aortic arch repair patients was significantly lower than that in the controls (489.3 ± 75.2 vs. 579.4 ± 106.0 mmHg/s, p = 0.013). The peak dP/dt in the DAo in aortic arch repair patients is low. The stiff repaired site may attenuate pulsation.
  • Ascending to descending aortic pulse pressure amplification in children.
    Tomoaki Murakami; Masahiro Shiraishi; Tomohiro Nawa; Atsuhito Takeda
    Journal of hypertension, 35, 7, 1411, 1415, 2017年07月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), INTRODUCTION: A peripheral pulse pressure (PP) is larger than a central PP (PP amplification). The phenomenon has been examined in adult, but not in children. METHODS: Fifty-four patients with a normal aorta were enrolled. The ascending and descending aorta pressure waveforms were recorded by a pressure sensor-mounted catheter. The difference of the PP, which was defined as the PP in the descending aorta minus that in the ascending aorta and the ratio of the PP, which was defined as the ratio of the descending to the ascending aortic PP, was examined as the index of the PP amplification. RESULTS: The patient's age was 6.2 ± 3.0 years. The difference of the PP was 4.5 ± 2.7 mmHg and had a significant positive relationship with the mean blood pressure (r = 0.46, P = 0.0005) and the age (r = 0.36, P = 0.009). The ratio of the PP was 1.14 ± 0.08 and had a significant positive relationship with the mean blood pressure (r = 0.42, P = 0.002) and the age (r = 0.29, P = 0.04). CONCLUSION: The PP amplification is observed even in children. The degree of the PP amplification increases with age during childhood contrary to the relationship in adults.
  • Loss of pulse pressure amplification between the ascending and descending aorta in patients after an aortic arch repair.
    Tomoaki Murakami; Masahiro Shiraishi; Tomohiro Nawa; Atsuhito Takeda
    Journal of hypertension, 35, 3, 533, 537, 2017年03月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), INTRODUCTION: One of the most important problems in patients with an aortic coarctation after an aortic arch repair is future cardiovascular disease. We previously reported the enhancement of the aortic pressure wave reflection in patients and hypothesized that the enhancement was caused by a new pressure wave reflection generated from the repaired site. To prove the hypothesis, we analyzed the pressure waveform in the ascending and descending aorta and examined their pulse pressure (PP) amplification. METHODS: Fifteen patients after an aortic arch repair without a recoarctation were enrolled. The ascending and descending aorta pressure waveforms were recorded by a pressure sensor mounted catheter. The pressures were compared with those of age-matched controls. RESULTS: The patient's age was 7.3 ± 2.7 years, and they underwent the aortic arch repair at 30.1 ± 29.0 days. The ascending aorta SBP (106.1 ± 12.7 mmHg) was higher than in the control patients (97.9 ± 14.3) (P = 0.015). The PP at the ascending aorta in the patients (41.3 ± 7.8) was wider than that in the controls (36.4 ± 5.0) (P = 0.010). There was no difference concerning the PP at the descending aorta between the patients (41.0 ± 7.7) and controls (40.5 ± 6.5). The difference in the PP between the descending and ascending aorta (PP at the descending aorta - PP at the ascending aorta) in the patients was -0.3 ± 1.7 and 5.1 ± 2.9 in the controls (P < 0.0001). CONCLUSION: The ascending aortic PP was augmented in the patients after the aortic arch repair. It could be one of the causes of future cardiovascular disease.
  • Sheath placement in femoral artery during cardiac catheterization in children can influence pressure waveform.
    Masahiro Shiraishi; Tomoaki Murakami; Tomohiro Nawa; Kouji Higashi; Hiromichi Nakajima; Hiroyuki Aotsuka
    International journal of cardiology, 230, 21, 24, 2017年03月01日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), INTRODUCTION: It is reported that pressure wave reflection is enhanced by external compression of the femoral artery. Therefore, it is possible that cardiac catheterization itself can influence the aortic pressure waveform. AIM: The purpose of this study is to clarify the influence of sheath placement in a femoral artery on the pressure waveform. METHODS: This study enrolled 21 pediatric patients (5.1±4.0years) who underwent cardiac catheterization. A sheath was placed in the femoral arteries of all patients. The change in the pressure waveform induced by the placement of the sheath was investigated using the b/a and d/a ratio of second derivative of a fingertip photoplethysmogram. A high b/a ratio means a stiff aorta and a low d/a ratio represents an enhancement of the aortic pressure wave reflection. RESULTS: By the placement of the sheath in their femoral arteries, the b/a ratio was not influenced (sheath (-): -0.556±0.081 vs. sheath (+): -0.558±0.072; p=0.896). However, the d/a ratio was significantly decreased (-0.150±0.074 vs. -0.185±0.084; p=0.0003). CONCLUSIONS: The placement of the femoral arterial sheath enhances the pressure wave reflection and would lead to a change in the central aortic pressure waveform.
  • Letter by Murakami et al Regarding Article, "Surgically Constructed Double-Outlet Right Ventricle".
    Tomoaki Murakami; Masahiro Shiraishi; Tomohiro Nawa
    Circulation, 134, 3, e16, 2016年07月19日, [査読有り], [国際誌]
    英語
  • Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant.
    Masahiro Shiraishi; Tomoaki Murakami; Tomohiro Nawa; Hironobu Kobayashi; Hiroki Nagamine; Kazuhiro Shiraga; Kouji Higashi; Hiromichi Nakajima
    International journal of cardiology, 215, 127, 8, 2016年07月15日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • N-terminal pro-brain natriuretic Peptide as a useful diagnostic marker of acute Kawasaki disease in children.
    Masahiro Shiraishi; Shigeto Fuse; Toshihiko Mori; Atsushi Doyama; Saho Honjyo; Yoko Hoshino; Emiko Hoshino; Azusa Kawaguchi; Yuki Kuroiwa; Tomoyuki Hotsubo
    Circulation journal : official journal of the Japanese Circulation Society, 77, 8, 2097, 101, 2013年, [査読有り], [国内誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Serum N-terminal pro-brain natriuretic peptide (NTproBNP) is often elevated in patients with acute Kawasaki disease (KD), but the NTproBNP level in normal children is higher than in adults. Thus, characterization of the normal levels and cut-off values of NTproBNP according to age is warranted for proper diagnosis of acute KD in children. METHODS AND RESULTS: Six hundred and fifty-five patients aged 1 month-15 years (median, 2.9 years) were included. Patients were admitted to the NTT East Japan Sapporo Hospital between October 2007 and October 2011. Serum NTproBNP level was examined in 149 patients with KD (median, 2.1 years) and 506 control patients with acute infectious disease (median, 3.2 years). In the control group, a Z-score curve of NTproBNP was generated for each age group using least mean square-based methods. The Z-score distribution of KD patients was then compared with that of the control group. The specificity and sensitivity of NTproBNP for diagnosing acute KD were 97.8% and 47.0%, respectively, at Z-score >2.0. Additionally, simple cut-offs every 100 pg/ml according to age were established for more convenient use at the bedside. CONCLUSIONS: The Z-score curve for NTproBNP in children was characterized. A Z-score >2.0 or the cut-off for children may be used to diagnose acute KD.
■ その他活動・業績
  • 小児における血管内皮グリコカリックス測定部位の検討 GlycoCheckを用いて
    白石 真大; 泉 岳; 斉藤 仁志; 加藤 裕貴; 糸洲 佑介; 土岐 崇幸; 佐藤 逸美; 加藤 伸康; 森本 裕二, 日本集中治療医学会雑誌, 32, Suppl.2, S602, S602, 2025年09月
    (一社)日本集中治療医学会, 日本語
  • フォンタン循環が微小循環に与える影響 血管内皮グリコカリックスへの負荷
    白石 真大; 泉 岳; 山澤 弘洲; 武田 充人; 加藤 伸康; 加藤 裕貴; 土岐 崇幸; 糸洲 佑介; 斉藤 仁志; 森本 裕二, 日本小児循環器学会総会・学術集会抄録集, 61回, I, 01, 2025年07月
    (NPO)日本小児循環器学会, 日本語
  • PEGコーティングによるミトコンドリアの表面加工技術
    白石 真大; 村松 ゆかり; 中谷 彰洋; 丸尾 優爾; 太田 尚; 菅沼 正司; Tsai Rick C.; 原島 秀吉; 山田 勇磨, 日本DDS学会学術集会プログラム予稿集, 41回, 303, 303, 2025年06月
    日本DDS学会, 日本語
  • MICROCIRCULATORY ALTERATIONS IN FONTAN CIRCULATION: LOAD ON VASCULAR ENDOTHELIAL GLYCOCALYX
    Masahiro Shiraishi; Gaku Izumi; Hirokuni Yamazawa; Atsuhito Takeda; Nobuyasu Kato; Hiroki Kato; Takayuki Toki; Yusuke Itosu; Hitoshi Saito; Yuji Morimoto, JOURNAL OF HYPERTENSION, 43, SUPPL 1, 2025年05月
    英語, 研究発表ペーパー・要旨(国際会議)
  • コエンザイムQ10のミトコンドリア送達によるミトコンドリア機能活性化間葉系幹細胞の確立
    MARUO Yuji; 白石真大; 日比野光恵; 阿部二郎; 阿部二郎; 武田充人; 山田勇磨; 山田勇磨, 日本小児科学会雑誌, 129, 2, 2025年
  • 心疾患治療への応用を目指したミトコンドリア標的型Drug Delivery Systemによる移植幹細胞の機能改変
    丸尾優爾; 丸尾優爾; 白石真大; 日比野光恵; 佐々木大輔; 阿部二郎; 阿部二郎; 武田充人; 山田勇磨, 日本小児循環器学会総会・学術集会(Web), 61st, 2025年
  • 急速に進行する肝不全で発症したwilson病に対して脳死肝移植を行い救命出来た14歳女児例
    佐藤逸美; 泉岳; 佐藤逸美; 泉岳; 川村典生; 白石真大; 白石真大; 土岐崇幸; 糸洲佑介; 加藤裕貴; 柿坂達彦; 後藤了一; 渡邊正明; 長津明久; 相山健; 武冨紹信; 斉藤仁志, 日本小児科学会雑誌, 129, 2, 2025年
  • Fontan循環における血管内皮グリコカリックスの検討
    白石 真大; 泉 岳; 斉藤 仁志; 加藤 裕貴; 西川 直樹; 糸洲 佑介; 武田 充人; 山澤 弘州; 加藤 伸康, 日本集中治療医学会雑誌, 31, Suppl.1, S624, S624, 2024年09月
    (一社)日本集中治療医学会, 日本語
  • ミトコンドリア標的型Drug Delivery Systemを使用した移植幹細胞の機能改変と心疾患治療への応用
    丸尾優爾; 白石真大; 佐々木大輔; 阿部二郎; 武田充人; 山田勇磨, 日本心臓病学会学術集会(Web), 72nd, 2024年
  • 体肺シャント(SPS)周術期に生じる肺高血圧クライシス(PHC)の危険因子:単施設後方視的観察研究
    泉岳; 白石真大; 糸洲佑介; 西川直樹; 加藤裕貴; 加藤伸康; 武田充人; 山澤弘州; 斉藤仁志; 森本裕二, 日本集中治療医学会学術集会(Web), 51st, 2024年
  • 主要体心室がFontan周術期に与えるインパクト
    松村優; 泉岳; 白石真大; 斉藤仁志; 加藤裕貴; 糸洲佑介; 西川直樹; 武田充人; 加藤伸康; 森本裕二, 日本集中治療医学会学術集会(Web), 51st, 2024年
  • オミックス解析がもたらす小児心血管疾患研究の新たな展開 メタボローム解析を用いたミトコンドリア活性化ヒト心筋前駆細胞移植法の効果検証
    白石 真大; 佐々木 大輔; 武田 充人; 原島 秀吉; 山田 勇磨, 日本小児循環器学会総会・学術集会抄録集, 59回, [III, 04], 2023年07月
    (NPO)日本小児循環器学会, 日本語
  • ミトコンドリア活性化心筋幹細胞移植療法の臨床応用に向けた取り組み
    白石 真大; 山田 勇磨; 佐々木 大輔; 武田 充人; 原島 秀吉, 日本小児循環器学会総会・学術集会抄録集, 58回, [III, 03], 2022年07月
    (NPO)日本小児循環器学会, 日本語
  • 僧帽弁形成術後12年経過し良好な経過が得られている乳児マルファン症候群の一例
    佐藤 逸美; 白石 真大; 辻岡 孝郎; 佐々木 大輔; 永井 礼子; 泉 岳; 山澤 弘州; 武田 充人, 日本小児循環器学会総会・学術集会抄録集, 58回, [III, 07], 2022年07月
    (NPO)日本小児循環器学会, 日本語
  • ミトコンドリア活性化ヒト由来心筋幹細胞を用いた細胞移植療法の検証
    白石 真大; 山田 勇磨; 佐々木 大輔; 日比野 光恵; 真栄城 正寿; 渡慶次 学; 武田 充人; 原島 秀吉, 日本DDS学会学術集会プログラム予稿集, 38回, 115, 115, 2022年06月
    日本DDS学会, 日本語
  • 小児期-若年成人における中心血圧推定 トノメトリー法を用いて
    村上 智明; 白石 真大; 武田 充人, 日本高血圧学会総会プログラム・抄録集, 43回, 265, 265, 2021年10月
    (NPO)日本高血圧学会, 日本語
  • 心筋症の基礎と臨床の架け橋を探る ヒト心筋前駆細胞を用いたミトコンドリア活性化心筋前駆細胞の製造および、心筋虚血再灌流モデルに対する細胞移植の治療効果の検討
    佐々木 大輔; 山田 勇磨; 後藤 悠太; 白石 真大; 武田 充人; 原島 秀吉, 日本小児循環器学会総会・学術集会抄録集, 57回, [I, 5], 2021年07月
    (NPO)日本小児循環器学会, 日本語
  • 小児肥大型心筋症に対するシベンゾリンの効果
    山澤 弘州; 武田 充人; 泉 岳; 永井 礼子; 佐々木 大輔; 辻岡 孝郎; 白石 真大; 佐藤 逸美, 日本小児循環器学会総会・学術集会抄録集, 57回, [OR19, 1], 2021年07月
    (NPO)日本小児循環器学会, 日本語
  • 先天性心疾患術後から乳び胸管理に難渋しリンパ管造影を実施したヌーナン症候群の乳児例
    佐藤 逸美; 白石 真大; 辻岡 孝郎; 佐々木 大輔; 永井 礼子; 泉 岳; 山澤 弘州; 武田 充人, 日本小児循環器学会総会・学術集会抄録集, 57回, [P32, 2], 2021年07月
    (NPO)日本小児循環器学会, 日本語
  • 小児心不全予後のsurrogate markerを考える 先天性僧帽弁閉鎖不全症における術前のpredictive Wall Stressは術後遠隔期左室機能のsurrogate markerとなりうるか
    白石 真大; 村上 智明; 佐藤 逸美; 辻岡 孝郎; 佐々木 大輔; 永井 礼子; 泉 岳; 山澤 弘州; 武田 充人, 日本小児循環器学会総会・学術集会抄録集, 57回, [I, 3], 2021年07月
    (NPO)日本小児循環器学会, 日本語
  • 心筋虚血再灌流モデルラットに対するヒトミトコンドリア強化心筋幹細胞移植療法の治療効果の検討
    佐々木 大輔; 山田 勇磨; 後藤 悠太; 白石 真大; 武田 充人; 原島 秀吉, 日本DDS学会学術集会プログラム予稿集, 37回, 99, 99, 2021年06月
    日本DDS学会, 日本語
  • 【周産期の薬】新生児編 疾患に対する薬剤の選び方・使い方・注意点 循環器系疾患 心不全・ショック(左心低形成症候群)
    白石 真大, 周産期医学, 50, 増刊, 526, 529, 2020年12月
    (株)東京医学社, 日本語
  • 心不全「小児心不全薬物治療ガイドラインUpdate」 先天性心疾患の慢性心不全治療 心保護薬のエビデンス
    白石 真大, 日本小児循環器学会雑誌, 36, Suppl.2, s2, 126, 2020年11月
    (NPO)日本小児循環器学会, 日本語
  • “肺動脈性”肺高血圧症の境界線は,私達が想像していた以上に曖昧である-PAH with overt features of PVOD/PCH involvement-
    永井礼子; 永井礼子; 佐藤逸美; 白石真大; 佐々木大輔; 泉岳; 山澤弘州; 武田充人, 日本小児循環器学会雑誌, 36, Supplement 2, 2020年
  • post tolvaptan eraのうっ血解除戦術〜利尿薬をどのように使うか 小児うっ血性心不全に対する高張食塩水とフロセミド併用治療
    白石 真大; 村上 智明; 東 浩二, 日本小児循環器学会雑誌, 35, Suppl.1, s1, 127, 2019年06月
    (NPO)日本小児循環器学会, 日本語
  • 明日からできる心血管機能研究 小児における脈波解析 圧波形からわかること
    白石 真大; 村上 智明, 日本小児循環器学会雑誌, 35, Suppl.1, s1, 160, 2019年06月
    (NPO)日本小児循環器学会, 日本語
  • 【私の処方2018】循環器疾患の処方 心不全
    白石 真大; 村上 智明, 小児科臨床, 71, 5, 703, 710, 2018年05月
    (株)日本小児医事出版社, 日本語
  • 大血管スイッチ手術後患児修学期の脈圧増幅
    村上 智明; 武田 充人; 白石 真大, 日本小児科学会雑誌, 122, 2, 542, 542, 2018年02月
    (公社)日本小児科学会, 日本語
  • 【新生児の薬物療法-update】循環器用薬 抗心不全薬
    白石 真大; 村上 智明, 周産期医学, 48, 2, 169, 172, 2018年02月
    (株)東京医学社, 日本語
  • 大動脈修復術後は下行大動脈のpeak dP/dtが低下する
    白石 真大; 村上 智明; 武田 充人, 日本小児循環器学会雑誌, 33, Suppl.1, s1, 377, 2017年07月
    (NPO)日本小児循環器学会, 日本語
  • 【保存版 新生児の代表的疾患と病態生理 マスターブック 病因から臨床症状、治療、予後までを網羅!】(第2章)循環器系の生理と代表的疾患 大動脈縮窄(CoA) 大動脈弓離断(IAA)
    白石 真大; 村上 智明, Neonatal Care, 2017春季増刊, 76, 80, 2017年03月
    (株)メディカ出版, 日本語
  • 脈波解析の基礎 応用を巡る問題点 脈波波形関連指標 大腿動脈にカテーテルシースを留置することで反射波は増大する
    白石 真大; 村上 智明; 名和 智裕; 東 浩二; 中島 弘道; 青墳 裕之, 日本臨床生理学会雑誌, 46, 4, 74, 74, 2016年10月
    日本臨床生理学会, 日本語
  • 大動脈修復術後の圧反射 脈圧増幅の解析
    村上 智明; 白石 真大; 名和 智裕; 武田 充人, 日本高血圧学会総会プログラム・抄録集, 39回, 368, 368, 2016年09月
    (NPO)日本高血圧学会, 日本語
  • 大動脈修復術後のpulse pressure amplification 正常大動脈との比較
    村上 智明; 名和 智裕; 白石 真大; 武田 充人, 日本心臓病学会学術集会抄録, 64回, P, 359, 2016年09月
    (一社)日本心臓病学会, 日本語
  • 小児におけるPulse Pressure Amplification
    村上 智明; 名和 智裕; 白石 真大; 武田 充人, 日本小児科学会雑誌, 120, 2, 315, 315, 2016年02月
    (公社)日本小児科学会, 日本語
  • 骨髄炎を併発した劇症型A群溶血性レンサ球菌感染症の1例
    星野 恵美子; 白石 真大; 土山 厚志; 黒岩 由紀; 森 俊彦, 小児感染免疫, 26, 2, 225, 230, 2014年07月
    日本小児感染症学会, 日本語
  • アナフィラキシー型小麦アレルギーに対し急速特異的経口耐性誘導(rush SOTI)が奏効した1例
    土山 厚志; 白石 真大; 本庄 紗帆; 星野 陽子; 星野 恵美子; 河口 亜津彩; 黒岩 由紀; 母坪 智行; 布施 茂登; 森 俊彦, 臨床小児医学, 61, 1-6, 37, 40, 2013年12月
    (財)小児愛育協会, 日本語
  • 同時期にHaemophilus influenzae type b髄膜炎を発症した一卵性双生児の兄弟例
    森 俊彦; 白石 真大; 星野 恵美子; 黒岩 由紀, 小児感染免疫, 25, 3, 297, 302, 2013年10月
    日本小児感染症学会, 日本語
  • 甲状腺腫瘍との鑑別に苦慮した非定型的な化膿性甲状腺炎の1例
    星野 陽子; 白石 真大; 土山 厚志; 中 智昭; 久田 諒; 本庄 紗帆; 星野 恵美子; 河口 亜津彩; 黒岩 由紀; 母坪 智行; 布施 茂登; 森 俊彦; 劉 澤周; 小崎 真也, 臨床小児医学, 60, 1-6, 31, 34, 2012年12月
    (財)小児愛育協会, 日本語
  • ダブルバルーン小腸内視鏡検査で診断に至った橋本病に合併した小腸Crohn病(CD)の1例
    本庄 紗帆; 白石 真大; 土山 厚志; 星野 陽子; 星野 恵美子; 河口 亜津彩; 黒岩 由紀; 母坪 智行; 布施 茂登; 森 俊彦; 赤倉 伸亮, 臨床小児医学, 60, 1-6, 39, 42, 2012年12月
    (財)小児愛育協会, 日本語
■ 所属学協会
  • 日本DDS学会
  • 日本集中治療医学会(専門医)
  • 日本小児循環器学会 (専門医・評議員)
  • 日本小児科学会 (専門医・学会認定指導医)
■ 学術・社会貢献活動/その他
メディア報道
  • 北大、ミトコンドリアを活性化させ心機能改善効果を強化したヒト心筋前駆細胞を開発
    2024年02月
    日経バイオテク
    [インターネットメディア]
その他
  • PALSインストラクター